The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine

Sexually Transmitted Diseases

Volumn 33, Issue 10 SUPPL., 2006, Pages

  Vickerman, Peter ^a   Kumaranayake, Lilani ^a   Balakireva, Olga ^b   Guinness, Lorna ^a   Artyukh, Oksana ^b   Semikop, Tatiana ^c   Yaremenko, Olexander ^b   Watts, Charlotte ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Ukrainian Research Inst of Aviation   (Ukraine)

^c Faith Hope and Love   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG ABUSE; HARM REDUCTION; HEALTH ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PREVALENCE; STATISTICAL ANALYSIS; UKRAINE; WORLD HEALTH ORGANIZATION;

ADULT; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MALE; MODELS, ECONOMIC; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; UKRAINE; URBAN POPULATION;

EID: 33745885089     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000221335.80508.fa     Document Type: Article

References (24)

1. Garnett GP, Anderson RM. Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations. IMA J Math Appl Med Biol 1994 11: 161-192.
2. Weinstein MC, Graham JD, Siegel JE, Fineberg HV. Cost-effectiveness analysis of AIDS prevention programs: concepts, complications and illustrations. In: Confronting AIDS: Sexual behaviour and intravenous drug use. Turner CF, Miller HG, Moses LE (Turner CF, Miller HG, Moses LEs). Washington DC: National Academy Press; 1989:471-499.
3. Pitcher CD, Tien H, Vernazza PL, Stewart P, Chakraborty H, Eron JJ, Jr., et al. Semen viral dynamics in acute HIV infection: implications for sexual transmission [Abstract ThOrC1489]. 14th International AIDS Conference. Barcelona, Spain 2002.
4. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo N, Serwadda D, Wabwire Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357:1149-1153.
5. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine 2000, 342:921-929.
6. Royce RA, Sena A, Cates W, Jr, Cohen MS. Sexual transmission of HIV. New England Journal of Medicine 1997 336:1072-1078.
7. Louria DB, Skurnick JH, Palumbo P, Bogden JD, Rohowsky Kochan C, Denny TN, et al. HIV heterosexual transmission: a hypothesis about an additional potential determinant. International Journal of Infectious Diseases 2000, 4:110-116.
8. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. British medical Journal 1992, 304:809-813.
9. Hudgens MG, Longini IM, Jr, Vanichseni S, Hu DH, Kitayaporn D, Mock PA, et al. Subtype-specific transmission probabilities for Human Immunodeficiency Virus among injecting drug users in Bangkok, Thailand. American Journal of Epidemiology 2002 155:159-168.
10. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. Journal of Acquired Immune Deficiency Syndrome 1992, 5:1116-1118.
11. Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001, 15:621-627.
12. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Research and Human Retroviruses 2001, 17:901-910.
13. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Family Planning Perspectives 1999, 31:272-279.
14. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Social Science and Medicine 1997, 44:1303-1312.
15. Shah SM, Shapshak P, Rivers JE, Stewart RV, Weatherby NL, Xin KQ, et al. Detection of HIV-1 DNA in needle/syringes, paraphernall, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:301-306.
16. Shapshak P, McCoy CB, Shah SM, Page JB, Rivers JE, Weatherby NL, et al. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. Journal of Acquired Immune Deficiency Syndrome 1994, 7:754-759.
17. Titus S, Marmor M, Des Jarlai D, Kim M, Wolfe H, Beatrice S. Bleach use and HIV seroconversion among New York City injection drug users. J Acquir Immune Defic Syndr 1994. 7:700-704.
18. Ross MW, Wodak A, Gold J. The association of needle cleaning with reduced seroprevalence among intravenous drug users sharing injection equipment [letter]. J Acquir Immune Defic Syndr 1992, 5:849-850.
19. Monterroso ER, Hamburger ME, Vlahov D, Des Jarlais DC, Ouellet LJ, Altice FL, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr 2000, 25:63-70.
20. Marmor M, Des Jarlais DC, Cohen H, Friedman SR, Beatrice ST, Dubin N, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987, 1:39-44.
21. Flynn N, Jain S, Keddie EM, Carlson JR, Jennings MB, Haverkos HW, et al. In vitro activity of readily available household materials against HIV-1: is bleach enough? Journal of Acquired Immune Deficiency Syndrome 1994,7;747-753.
22. Contoreggi C, Jones S, Simpson P, Lange WR, Meyer WA, 3rd. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use. Intervirology 2000, 43:1-5.
23. Abdala N, Stephens PC, Griffith BP, Heimer R. Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol 1999 20:73-80.
24. Garnett GP, Hughes JP, Anderson RM, Stoner BP, Aral SO, Whittington WL, et al. Sexual-mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis 1996, 23:248-257.